CMPS
Compass Pathways Plc
Stock NASDAQ – Stock Market Prices, News & Analysis
Compass Pathways Plc is a biotechnology company focused on developing psilocybin-based therapies for the treatment of depression.
Compass Pathways Plc
CMPS
Compass Pathways Plc is a biotechnology company focused on developing psilocybin-based therapies for the treatment of depression.
Price history of Compass Pathways Plc
Price history of Compass Pathways Plc
Performance & Momentum
Strategic Analysis
Compass Pathways Plc • 2026
Compass Pathways Plc positions itself as an innovative player in the biotechnology sector by developing novel psilocybin-based therapies to treat depression, a market with a strong medical need. Its model relies on a disruptive therapeutic approach, with differentiating potential in an emerging field both in the UK and internationally.
Strengths
- Focus on an innovative medical segment with strong growth potential
- Advancement in the clinical development of psilocybin treatments
- Early positioning in a still minimally competitive market
Weaknesses
- Financial history marked by volatility and significant long-term losses
- Dependence on the success of clinical trials and regulatory approval
Momentum
The current momentum is very dynamic, supported by a significant rebound in performance over the last few months and renewed interest from investors. This positive trend reflects strengthened confidence in the outlook for clinical and commercial validation in the short to medium term.
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
